Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ.

"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using
a novel risk factor-based approach: the euro heart survey on atrial fibrillation."

Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. PMID: 19762550

I➜The CHA2DS2-VASc score predicts clinical risk of stroke and thromboembolism in atrial fibrillation. Developed on the same principles as the CHADS2 score it considers additional 'clinically relevant non-major' stroke risk factors: age 65-74, female gender and vascular disease. This results in better discrimination between high and low risk patient. The maximum CHADS2 score is 6, whilst the maximum CHA2DS2-VASc score is 9. Matching CHA2DS2-VASc score and HAS-BLED score allows the physician to choose the antithrombotic treatment tailored for every patient.


Never ignore professional medical advice in seeking treatment because of something you have read or use on this site.

Our online tools are addressed to health professionals and not to patients. In any case you may read our complete disclaimer.